Discover
FEMY
Femasys Inc.
2.59
2 x 1.84
2 x 3.50
bid
ask
+
0.04
1.57%
2 @ 04:00 PM
2.75 +0.16 (6.18%)
| Ytd | -77.52% | |
| 1y | -64.03% |
2.51
day range
2.64
2.02
52 week range
22.20
| Open | 2.51 | Prev Close | 2.55 | Low | 2.51 | High | 2.64 | Mkt Cap | 21.69M |
| Vol | 35.23K | Avg Vol | 719.00K | EPS | -2.72 | P/E | N/A | Forward P/E | -2.33 |
| Beta | -2.83 | Short Ratio | 3.67 | Inst. Own | 7.26% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.94 | 200-d Avg | 8.07 | 1yr Est | 8.25 |
FEMY News
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market ses
globenewswire.com
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women'
-- Leading multi-site OB/GYN health practice to implement FemVue ® for fertility diagnostic evaluati
benzinga.com
Femasys Files Prospectus Related To The Offer And Resale From Time To Time By The Selling Stockholde
https://www.sec.gov/Archives/edgar/data/1339005/000114036126035625/ny20081537x1_s3.htm
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular
benzinga.com
Femasys Partners With UNC Health To Introduce Fertility Diagnostics, FemVue And SpermVue, Together W
-- For the first time, OB/GYNs within the UNC Health system will be able to offer women FemVue® fert